In:
Cancer, Wiley, Vol. 129, No. 13 ( 2023-07), p. 2013-2022
Abstract:
The role of minimal residual disease (MRD) status pretransplantation in the survival of patients with myelodysplastic syndrome with excess blasts after allogeneic hematopoietic stem cell transplantation in present multicenter, retrospective, cohort study was evaluated. The primary outcome showed that MRD status was the only independent prognostic factor that affects long‐term survival.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v129.13
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
1429-1